DCGI approves Themis Medicare's VIRALEX for Covid-19 treatment
New Delhi [India], March 5 (ANI/Target Media): In a landmark development for the treatment of COVID-19, Themis...
SEC recommends granting emergency use authorisation to Serum...
DCGI gives emergency use authorisation to COVID-19 vaccine...
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received...
Corbevax COVID vaccine is safe, offers high antibody levels:...
SEC recommends COVID-19 vaccine Corbevax for 12-18 year age...
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee...
DCGI grants emergency-use approval to single-dose Sputnik...
New Delhi [India], February 6 (ANI): The Drugs Controller General of India (DCGI) has granted emergency-use...
Bharat Biotech gets DCGI's nod to conduct intranasal booster...
New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to...
DCGI grants conditional market approval for Covaxin, Covishield
New Delhi [India], January 27 (ANI): The Drugs Controller General of India (DCGI) on Thursday granted conditional...
Regular market approval to Covishield, Covaxin expected soon...
New Delhi [India], January 26 (ANI): The regular market approval from Drugs Controller General of India (DCGI) to...
Deaths have been considerably reduced due to COVID-19...
SEC recommends regular market approval to Covaxin, Covishield...
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee...
SEC asks for more data to grant full market approval to...
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee...
Copyright © aninews.in | All Rights Reserved.